
What is Ozempic and who is it for?
Ozempic (semaglutide) is a prescription medicine made by Novo Nordisk for adults with type 2 diabetes. It is FDA-approved to:
Improve blood sugar: with diet and exercise, in adults with type 2 diabetes.
Protect the heart: reduce the risk of cardiovascular death, heart attack and stroke in adults with type 2 diabetes and established cardiovascular disease.
Protect the kidneys: reduce the risk of kidney function getting worse, kidney failure and cardiovascular death in adults with type 2 diabetes and chronic kidney disease.
Ozempic also comes as a once-daily tablet for type 2 diabetes.

Ozempic or Wegovy?
Ozempic and Wegovy both contain semaglutide, but they are approved for different things and come in different doses.
Ozempic is approved for type 2 diabetes. Its highest dose is 2 mg a week.
Wegovy is approved for weight management and to reduce the risk of major cardiovascular events in adults with established cardiovascular disease and obesity or overweight. Its usual maintenance dose is 2.4 mg a week, and for weight in adults it can go to 7.2 mg.
Insurance plans treat them differently too: a plan may cover Ozempic for diabetes and Wegovy for weight under different rules. We sort that out before your first visit. Read about Wegovy.

How Ozempic works
Semaglutide acts like GLP-1, a hormone your gut releases after you eat.
Steadies blood sugar: it helps your body release insulin when blood sugar rises.
Quiets hunger: it signals your brain that you have had enough.
Keeps you full longer: food leaves your stomach more slowly.
Taking it safely
Ozempic is a once-weekly injection under the skin, on the same day each week, at any time of day, with or without food. Your physician starts with a low dose and raises it step by step, and your care team shows you how to inject.
Most side effects are stomach-related and ease as your body adjusts. Ozempic is not right for everyone, so your physician goes through your health history with you first. The details from the FDA label are below.
Dosing steps
- The label starts at 0.25 mg once a week for 4 weeks, then 0.5 mg a week.
- If more blood sugar control is needed, the dose can go to 1 mg after at least 4 weeks on 0.5 mg, then to 2 mg after at least 4 weeks on 1 mg.
- For chronic kidney disease, the maintenance dose is 1 mg a week.
- The highest dose is 2 mg a week.
Common side effects
- The most common side effects are nausea, vomiting, diarrhea, stomach pain and constipation.
- They are most likely when you start or raise the dose, and they often ease as your body adjusts.
Boxed warning
- In studies in rodents, semaglutide caused thyroid C-cell tumors. It is not known whether it causes these tumors, including medullary thyroid cancer, in people.
- Tell your physician right away about a lump or swelling in your neck, trouble swallowing, shortness of breath or hoarseness that does not go away.
Who should not take it
- Semaglutide is not for you if you or a family member has had medullary thyroid cancer (MTC), or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2).
- It is also not for anyone who has had a serious allergic reaction to semaglutide or to anything in the medicine.
- If you are pregnant or planning a pregnancy, tell your physician.
Less common but serious
- Problems listed on the label include inflammation of the pancreas, eye changes in people with diabetic eye disease, low blood sugar with insulin or a sulfonylurea, kidney problems from losing fluid, severe stomach problems, serious allergic reactions and gallbladder problems.
- Never share an Ozempic pen with anyone, even if the needle is changed.
- Tell your care team before any surgery or sedation: GLP-1 medicines can raise the risk of food getting into the lungs during anesthesia.
What Ozempic costs
With insurance: coverage depends on your plan. We check it before your first visit, submit any prior authorization for you and handle appeals if needed. Read how to check your GLP-1 coverage.
Copay help: we help you use the maker's copay assistance if you have commercial insurance.
Your visits: Most major insurance accepted, plus convenient cash pay options. Visits are billed to your insurance, and you pay any copay.
Medicare: we bill Medicare for visits.
Aayu Well's own self-pay plans are for compounded semaglutide and compounded tirzepatide. Compounded medicines are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. They are not the same as Ozempic or any brand-name medicine. Read about semaglutide options.
How Aayu Well helps
Insurance checked first: we look at your coverage before your first visit, so you know your options before you decide.
Prior authorization handled: our team prepares and submits it for brand-name medicine as a concierge service, and handles appeals if your plan says no.
Copay help: if you have commercial insurance, we help you use the maker's copay assistance.
A physician who knows you: Darshan Patel, MD, an obesity medicine physician, sees you by video or in person in Deer Park, Illinois, and adjusts your dose with you.
A registered dietitian: help with meals that fit your new appetite, protein on a GLP-1 and keeping your muscle.
A care team between visits: message us about side effects, doses or refills, and hear back from people who know your plan.
A plan for the long run: Do I have to take a GLP-1 forever?
We see patients in California, Georgia, Illinois, Indiana, Michigan, Ohio and Wisconsin.














